Tech Company Financing Transactions
Relmada Therapeutics Funding Round
Private investors invested in a $3.4 million funding round for Relmada Therapeutics. The financing round was announced on 5/20/2019.
Transaction Overview
Company Name
Announced On
5/20/2019
Transaction Type
Venture Equity
Amount
$3,414,505
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 43 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
880 3rd Ave. 12th Floor
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Website
Email Address
Overview
Relmada is a clinical stage pain management company with a diversified portfolio of products for the treatment of chronic pain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sergio Traversa
Chief Medical Officer
Ottavio Vitolo
VP - Operations
Gina DiGuglielmo
Browse more venture capital transactions:
Prev: 5/20/2019: Lane venture capital transaction
Next: 5/21/2019: Tachyus venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs